LVTX - LAVA Therapeutics NV

https://www.lavatherapeutics.com

Momentum: Bearish

Recent News

This Block Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Inspire Medical Systems ( NYSE:INSP ) , International Paper ( NYSE:IP )

Benzinga • 1 month, 1 week ago • score: 0.05

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keybanc analyst Brett Fishbin downgraded Inspire Medical Systems, Inc.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Lava Therapeutics BV, a biotechnology company, is dedicated to developing a portfolio of gamma-delta bispecific T-cell activators (gamma-delta bsTCE) for the treatment of solid tumors and hematologic malignancies based on its platform. The company is headquartered in Utrecht, the Netherlands.

52W High

$2.09

52W Low

$0.85

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.50

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

0.81

EV/Revenue (<3 favorable)

2.12

P/S (TTM) (<3 favorable)

8.28

P/B (<3 favorable)

2.07

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

33.55%

Institutions (25–75% balanced)

36.39%

Shares Outstanding

26,305,300

Float

10,222,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

4,990,000

Gross Profit (TTM)

-19,560,000

EPS (TTM)

-1.06

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-5.22%

ROE (TTM) (>15% strong)

-0.90%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

13.14

Momentum

Bearish momentum

Value

0.0204

0.0231

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025